Cipla gets nod to launch affordable Favipiravir in India for treatment of COVID-19 patients

Image Source : EUROPEAN PHARMA REVIEW Cipla gets nod to launch affordable Favipiravir in India for treatment of COVID-19 patients  Pharmaceutical firm Cipla is set to launch COVID-19 drug Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, stated an official statement. “Cipla has…

Read More Cipla gets nod to launch affordable Favipiravir in India for treatment of COVID-19 patients